CNE100005XJ7
CNE100005XJ7
SHANGHAI ALLIST PHARMACEUTICALS
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 5.187.338.134 | 3.557.930.156 | 45.8% |
| Cost of Revenue | 164.579.753 | 143.485.827 | 14.7% |
| Gross Profit | 5.022.758.381 | 3.414.444.329 | 47.1% |
| 2.541.392.875 | 1.877.232.255 | 35.4% | |
| Operating Income | 2.481.365.506 | 1.537.212.073 | 61.4% |
| Pretax Income | 2.544.937.734 | 1.618.521.345 | 57.2% |
| Net Income Common Stockholders | 2.189.104.957 | 1.429.847.079 | 53.1% |
| -- | -- | -- | |
| -- | -- | -- |